A Study To Investigate The Taste Of Crizotinib Liquid In Trained Healthy Adult Volunteers
This study has been completed.
Information provided by:
First received: May 17, 2010
Last updated: July 21, 2010
Last verified: July 2010
An oral-liquid, pediatric form of crizotinib designed for use by pediatric patients is being tested for its' palatability in adults.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
|Official Title:||A Study In Trained Taste Panel Healthy Adult Volunteers To Investigate The Palatability Of Select Formulations Of Crizotinib Oral Liquid|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Pfizer:
Primary Outcome Measures:
- A complete description of the sensory attributes of drug product prototype formulations (eg, aroma, flavor, texture, and mouthfeel). [ Time Frame: 2 months ] [ Designated as safety issue: No ]
|Study Start Date:||June 2010|
|Study Completion Date:||June 2010|
|Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
Oral liquid. Taste assessment of new formulation. Subjects will not ingest the drug.
Taste assessment of new formulation. Subjects will not ingest the drug.
Contacts and Locations